Evidence map›Paper›PMID 41697381›Full record

ArticleBiotechnology letters2026

Recombinant erythropoietin expression elevates by ubiquitous chromatin opening element (UCOE) in CHO DG44 cells.

Fateme Hasheminejad, Haniyeh Norouzi, Seyede Hoda Jazayeri, Zahra Halfinezhad, Abbas Daneshipour, Zeynab Khoshnood, Mahsa Nejati, Fatemeh Norouzi, Somayeh Abolghasemi, Mohsen Gharanfoli and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Biotechnology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Fateme Hasheminejad *Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
Haniyeh Norouzi *Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
Seyede Hoda JazayeriDepartment of Developmental Biology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Zahra HalfinezhadDepartment of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
Abbas DaneshipourDepartment of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
Zeynab KhoshnoodDepartment of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
Mahsa NejatiDepartment of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
Fatemeh NorouziDepartment of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
Somayeh AbolghasemiDepartment of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
Mohsen GharanfoliDepartment of Cell and Molecular Biology Science, Faculty of Sciences and Advanced Technologies in Biology, University of Science and Culture, Tehran, Iran.
Sara TaleahmadDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. s.taleahmad@royan-rc.ac.ir.
Amir Amiri-YektaDepartment of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran. amir.amiriyekta@royaninstitute.org.ORCID http://orcid.org/0000-0002-8099-7984

Funding

Royan Institute 99000004
6 · The paper itself

Abstract

The growing demand for biopharmaceuticals has increased the need for efficient and cost-effective recombinant protein production platforms. Transcriptional gene silencing after random genomic integration of expression vectors remains a major limitation in mammalian expression systems and often reduces protein yield. Incorporation of ubiquitous chromatin opening elements (UCOEs) into expression cassettes has emerged as a promising strategy to mitigate position effects and enhance transgene expression. This study examined the effect of a UCOE-containing expression system on erythropoietin (EPO) production in Chinese hamster ovary (CHO) DG44 cells. A codon-optimized EPO expression cassette was introduced into CHO DG44 cells using either a conventional pOptiVEC vector and a UCOE-containing vector following random genomic integration. Recombinant EPO expression was assessed at the transcriptional and protein levels using reverse transcription quantitative polymerase chain reaction (RT-qPCR), western blotting, and enzyme-linked immunosorbent assay (ELISA). The UCOE-containing cell pool exhibited a significant enhancement in recombinant EPO expression, with approximately a 3.8-fold increase in mRNA levels and a sevenfold increase in secreted protein levels compared to the non-UCOE control cell pool. These results show that incorporating a UCOE reduces position-dependent gene silencing and increases recombinant mRNA and protein expression in CHO DG44 cell pools. This strategy supports improved efficiency during the early stages of cell line development for recombinant protein production.

Indexed as

ChromatinErythropoietinRecombinant ProteinsAnimalsCHO CellsCricetinaeCricetulusGenetic VectorsChromatinErythropoietinRecombinant ProteinsCHO DG44ErythropoietinRecombinant proteinUbiquitous chromatin opening elements

Identifiers

PMID41697381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.